Background Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic
hematopoietic cell transplant (alloHCT). Method We analyzed 159 alloHCT recipients with …

Purpose. The novel and traditional risk factors for cytomegalovirus (CMV) infection and
disease in solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) …

Cytomegalovirus (CMV) disease is a major cause of infectious complications in allogeneic
hematopoietic stem cell transplantation (allo-HSCT). Although patients undergoing allo …

As one of the 8 human herpes viruses (designated human herpes virus 5), CMV shares
characteristics with other herpes viruses including virion and genome structure and the …

The management of cytomegalovirus (CMV) infection was assessed with a survey
performed in 2020 by the Infectious Diseases Working Party of European Society for Blood …

ABSTRACT Introduction: Human Cytomegalovirus (CMV) remains a major cause of
morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Standard …

BACKGROUND AND OBJECTIVE: Human cytomegalovirus (HCMV) infection and disease
remain a major cause of morbidity and mortality after bone marrow transplantation. HCMV …

Cytomegalovirus (CMV) infection is a potentially life-threatening complication after
hematopoietic cell transplantation (HCT). The potential availability of novel preventive …

Background: Despite diagnostic and therapeutic advances, cytomegalovirus (CMV) infection
has remained a significant complication after hematopoietic stem cell transplantation …

Introduction: There is a high prevalence of cytomegalovirus (CMV) seropositivity in
developing countries. An apparent risk of CMV reactivation increases following …